Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Cell-Free Nucleic Acids Circulating in the Plasma of Colorectal Cancer Patients Induce the Oncogenic Transformation of Susceptible Cultured Cells
2010
Circulating microRNAs as stable blood-based markers for cancer detection
2008 Standout
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing
2012
fastp: an ultra-fast all-in-one FASTQ preprocessor
2018 Standout
Quantification of Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
2008
Noninvasive in vivo monitoring of tissue-specific global gene expression in humans
2014
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
2018
Functionality of Circulating DNA
2001
Cell-free circulating tumor DNA in cancer
2016
The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients
2009
Detection and Monitoring of Cell‐Free DNA in Blood of Patients with Colorectal Cancer
2008
Circulating Nucleic Acids in Plasma or Serum (CNAPS) as Prognostic and Predictive Markers in Patients with Solid Neoplasias
2005
Nasopharyngeal carcinoma
2005 Standout
Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients
2003
Netting neutrophils in autoimmune small-vessel vasculitis
2009 Standout
Regulation of microRNA function in animals
2018 Standout
Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease
2010
Novel Strategies for the Early Detection and Prevention of Lung Cancer
2005
The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells
2005
A view on drug resistance in cancer
2019 StandoutNature
Comparative Analysis of Mesenteric and Peripheral Blood Circulating Tumor DNA in Colorectal Cancer Patients
2006
Liquid biopsy: monitoring cancer-genetics in the blood
2013
Salivary Transcriptomic Biomarkers for Detection of Resectable Pancreatic Cancer
2009
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
The biology and management of non-small cell lung cancer
2018 StandoutNature
Detection of Microsatellite Alterations in the DNA Isolated from Tumor Cells and from Plasma DNA of Patients with Lung Cancer
2000
Quantitative Analysis of Epstein‐Barr Virus DNA in Plasma and Serum
2001
Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients
2002
Microsatellite analysis of serum DNA in patients with head and neck cancer
2004
Impact of platinum‐based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients
2010
Lung Cancer
2008 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
The power and the promise of DNA methylation markers
2003
Circulating cell-free and Epstein–Barr virus DNA in pediatric B-non-Hodgkin lymphomas
2010
Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA
2007
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Pancreatic cancer
2016 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators
2007
The Emerging Role of “Liquid Biopsies,” Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations
2017
Plasma Epstein-Barr Virus DNA and Residual Disease After Radiotherapy for Undifferentiated Nasopharyngeal Carcinoma
2002
Preoperative evaluation and management of the pancreatic head mass
2012
Human papillomavirus DNA in plasma of patients with cervical cancer
2001
Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer
2009
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
Epigenetics in Cancer
2008 Standout
Metagenomic biomarker discovery and explanation
2011 Standout
Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma
2007
Detection and Clinical Importance of Micrometastatic Disease
1999
Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression
2011
Cancer genes and the pathways they control
2004 Standout
DNA‐Based Detection of Prostate Cancer in Blood, Urine, and Ejaculates
2001
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Pre-eclampsia
2005 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Gene methylation and early detection of genitourinary cancer: the road ahead
2007
Multimodal biomedical AI
2022 Standout
Circulating Nucleic Acids in Plasma and Serum
2008
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
2009
Emerging molecular markers of cancer
2002
Tumor-specific DNA in plasma of breast cancer patients
2002
Nasopharyngeal carcinoma
2015 Standout
Detection of p53 mutations in the plasma DNA of patients with ovarian cancer
2004
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance
2007
Strategies for early detection of resectable pancreatic cancer
2014
Presence of fetal DNA in maternal plasma and serum
1997 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer
2005
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Clinical relevance of circulating cell-free microRNAs in cancer
2014
Nucleosomal DNA Fragments in Autoimmune Diseases
2006
Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer
2006
Circulating mutant DNA to assess tumor dynamics
2008 Standout
Detection of free‐circulating tumor‐associated DNA in plasma of colorectal cancer patients and its association with prognosis
2002
Next-generation DNA sequencing
2008 Standout
Detection of tumor‐specific DNA in blood and bone marrow plasma from patients with prostate cancer
2007
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal Diagnosis
1998 Standout
Circulating Nucleic Acids in Plasma and Serum
2006
Nucleosomes in serum of patients with benign and malignant diseases
2001
Microsatellite alterations in serum DNA of head and neck cancer patients
1996
Circulating DNA Microsatellites: Molecular Determinants of Response to Biochemotherapy in Patients With Metastatic Melanoma
2004
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy
2011
Comparison of plasma Epstein–Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma
2004
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
2010 Standout
Fetal cells and cell-free fetal DNA in maternal blood: new insights into pre-eclampsia
2002
Role of Cell‐Free Plasma DNA as a Diagnostic Marker for Prostate Cancer
2004
Circulating nucleic acids (CNAs) and cancer—A survey
2006
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Circulating tumour‐associated plasma DNA represents an independent and informative predictor of prostate cancer
2006
The fundamental role of epigenetic events in cancer
2002 Standout
Clinical Relevance of Circulating Nucleosomes in Cancer
2008
The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma
2006
A Noninvasive System for Monitoring Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors with Plasma DNA
2011
Circulating nucleic acids in plasma/serum
2007
Breast cancer metastasis: markers and models
2005 Standout
Plasma cell‐free DNA in ovarian cancer
2010
Head and Neck Cancer
2001 Standout
Real-time reverse transcription PCR and the detection of occult disease in colorectal cancer
2006
Prognostic value of circulating KRAS2 gene mutations in colorectal cancer with distant metastases
2006
Cancer biomarkers: Written in blood
2014 Nature
Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.
2002
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
2011 Standout
Allelic Imbalance on 12q22-23 in Serum Circulating DNA of Melanoma Patients Predicts Disease Outcome
2004
Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA.
2000
Feasibility and relevance of global expression profiling of gene transcripts in serum from breast cancer patients using whole genome microarrays and quantitative RT-PCR.
2008
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
2009
Soluble normal and mutated DNA sequences from single-copy genes in human blood.
1994
Characterization of Amplifiable, Circulating RNA in Plasma and Its Potential as a Tool for Cancer Diagnostics
2004
Molecular detection of genetic alterations in the serum of colorectal cancer patients.
1998
Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.
2002
Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma.
1998
Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.
1999
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Molecular Detection of APC, K‐ras, and p53 Mutations in the Serum of Colorectal Cancer Patients as Circulating Biomarkers
2004
Association of Circulating Tumor Cells with Serum Tumor-Related Methylated DNA in Peripheral Blood of Melanoma Patients
2006
Preoperative Serum DNA GSTP1 CpG Island Hypermethylation and the Risk of Early Prostate-Specific Antigen Recurrence Following Radical Prostatectomy
2005
Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
2002
Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma.
1999
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer
2009
Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
2001
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
The Mutation Rate and Cancer
1998
Prognostic Value of Circulating KRAS2 Gene Mutations in Colorectal Cancer with Distant Metastases
2006
Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.
2002
Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor
2007
Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.
2002
Prospective Study of Quantitation of Plasma DNA Levels in the Diagnosis of Malignant versus Benign Prostate Disease
2005
Nucleic Acid-Based Methods for the Detection of Cancer
1997 Science
Circulating Mitochondrial Nucleic Acids Have Prognostic Value for Survival in Patients with Advanced Prostate Cancer
2007
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.
1999
Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.
2001
Preterm labor: One syndrome, many causes
2014 StandoutScience
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
2014
Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.
2000
K-ras Mutations in DNA Extracted From the Plasma of Patients With Pancreatic Carcinoma: Diagnostic Utility and Prognostic Significance
1999
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer.
2000
Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.
1999
Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer
1997
Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.
2001
Quantitative Analysis of Cell-Free Epstein-Barr Virus DNA in Plasma of Patients with Nonnasopharyngeal Head and Neck Carcinomas
2004
Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.
2000
Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.
2001
Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer
2003
Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue.
2004
DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.
2001 Standout
Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients.
2000
Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing
2012
Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
2003
14-3-3σ Methylation in Pretreatment Serum Circulating DNA of Cisplatin-Plus-Gemcitabine-Treated Advanced Non–Small-Cell Lung Cancer Patients Predicts Survival: The Spanish Lung Cancer Group
2005
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Extracellular Tyrosinase mRNA within Apoptotic Bodies Is Protected from Degradation in Human Serum
2001
Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma.
2000
Stability of Endogenous and Added RNA in Blood Specimens, Serum, and Plasma
2002
Works of C Lederrey being referenced
Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients
1989
Point mutations of the N‐ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia
1994
About the possible origin and mechanism of circulating DNA
2001
K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer
1997
Plasma DNA K‐ras Mutations in Patients with Gastrointestinal Malignancies
2000
Microsatellite alterations in plasma DNA of small cell lung cancer patients
1996
Alu Repeat Sequences Are Present in Increased Proportions Compared to a Unique Gene in Plasma/Serum DNA
2001
Circulating nucleic acids in plasma or serum
2001
Isolation and characterization of DNA from the plasma of cancer patients
1987
The Origin and Mechanism of Circulating DNA
2000
THE ROLE OF EXTRACELLULAR DNA IN THE TRANSFER OF INFORMATION FROM T TO B HUMAN LYMPHOCYTES IN THE COURSE OF AN IMMUNE RESPONSE
1980
Telomerase RNA as a detection marker in the serum of breast cancer patients.
2000
A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.
1998
[Transformation of NIH/3T3 cells and SW 480 cells displaying K-ras mutation].
1994
Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture.
1978
Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.
1999